TRIJARDY XR

Peak

empagliflozin, linagliptin, metformin hydrochloride

NDAORALTABLET, EXTENDED RELEASE
Approved
Jan 2020
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

Dipeptidyl Peptidase 4 Inhibitors

Pharmacologic Class:

Dipeptidyl Peptidase 4 Inhibitor

Loss of Exclusivity

LOE Date
Dec 8, 2037
143 months away
Patent Expiry
Dec 8, 2037

Patent Records (5)

Patent #ExpiryTypeUse Code
8883805
Nov 26, 2025Expired
Product
8883805*PED
May 26, 2026
7713938
Apr 15, 2027
SubstanceProduct
7713938*PED
Oct 15, 2027
7579449
Aug 1, 2028
Substance